American Express Stock (AXP) Opinions on Analyst Price Target Reductions - Quiver Quantitative
π Analyst Barclays recently lowered its price target for American Express (AXP) from $367 to $323 amid a broader 17% year-to-date stock decline.
π³ Despite the short-term downturn, users highlight AXP's robust pricing power with average card fees increasing every quarter for nearly a decade.
π€ Bulls argue that American Express is well-positioned to benefit from surging AI-related fraud due to its role as a payment network buffer.
π¦ Warren Buffett's continued presence in the firm's top holdings and its appeal to high-spending consumers bolster long-term optimism.
π Technical analysts note potential breakout support at $310, with targets extending to $325 following the formation of daily timeframe support.
π― Insider trading data shows a net selling pattern, with American Express insiders executing 19 stock sales and zero purchases in the past six months.
βοΈ Members of Congress have traded AXP stock 10 times recently, resulting in a net positive flow of six purchases versus four sales.
ποΈ Institutional investors saw slight divergence recently, with 1,270 adding shares to portfolios while 1,201 decreased their positions in the last quarter.
π° American Express reported Q4 2025 revenues of $17.6 billion, representing a 10.57% increase compared to the same period in the prior year.
π The median analyst price target set for AXP over the last six months stands at $345.0 based on inputs from eight different analysts.
- American Express demonstrates enduring pricing power, having raised average fees per card every quarter for nearly a decade.
- The stock is supported by inclusion in Warren Buffett's top holdings and strong appeal to high-spending consumers.
- Technical analysis indicates a potential breakout above $310, with analysts targeting $325.
- Recent revenue grew 10.57% year-over-year to $17.6B in Q4 2025.
- Members of Congress have shown bullish conviction by purchasing shares 6 times in the past 6 months.
- Barclays recently lowered its price target from $367 to $323, reflecting significant analyst bearishness despite the stock's robust fundamentals.
- The stock has already experienced a severe 17% year-to-date decline, indicating substantial short-term selling pressure.
- Insider trading data shows a heavy sell-off by company insiders over the past six months, with all 19 transactions being sales and no purchases recorded.
- Institutional investors are showing mixed signals for the upcoming quarter, with 1,201 institutions reducing their positions compared to only 1,270 adding shares.
- Of the 8 analysts who issued price targets in the last six months, a significant reduction in coverage occurred at the median target of $345.0.